Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-23-050314
Filing Date
2023-10-31
Accepted
2023-10-30 17:46:53
Documents
11
Effectiveness Date
2023-10-31

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ny20009756x9_s8.htm S-8 58060
2 EXHIBIT 4.4 ny20009756x9_ex4-4.htm EX-4.4 15378
3 EXHIBIT 4.6 ny20009756x9_ex4-6.htm EX-4.6 31603
4 EXHIBIT 4.7 ny20009756x9_ex4-7.htm EX-4.7 181587
5 EXHIBIT 5.1 ny20009756x9_ex5-1.htm EX-5.1 9739
6 EXHIBIT 23.1 ny20009756x9_ex23-1.htm EX-23.1 2555
7 EXHIBIT 23.2 ny20009756x9_ex23-2.htm EX-23.2 2524
8 EXHIBIT 99.1 ny20009756x9_ex99-1.htm EX-99.1 196349
9 FILING FEES TABLE ny20009756x9_ex107.htm EX-FILING FEES 12946
10 ny20009756x9_ex5-1img01.jpg GRAPHIC 5424
11 ny20009756x9_ex5-1img02.jpg GRAPHIC 2563
  Complete submission text file 0001140361-23-050314.txt   523192
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 650-266-8674
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275222 | Film No.: 231361721
SIC: 2834 Pharmaceutical Preparations